Search companies

Live

Tuesday, 17 November 2026 · 580 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

BCAL Director Adds Shares Through On-Market Purchase

BDX: $0.064 +0.00% · MC: $22M

BCAL Diagnostics director Jayne Shaw acquired 72,315 shares on market, increasing the holding in her family account while her other disclosed holdings remained unchanged. The purchase was made on 5 November.

Source announcements: 2026-11-11 15:45 to 2026-11-11 15:45 Sydney time
Story updated 2026-11-11 15:49 Sydney time
SourcesChange of Director's Interest Notice
Comments